This episode of the Device Week podcast covers Cognoa’s development of an app to detect autism spectrum disorder early, Novocure’s customer-focused strategy during the pandemic, and the new $585m fund created by Longitude Capital to invest in medtech, pharma and biotech.

Medtech Insight articles addressing topics discussed in this episode:

Cognoa Seeks De Novo Clearance For AI-Powered Diagnostic App For Autism After Successful Study https://bit.ly/2RVDqtU

Novocure Transforms Patient Support System During Pandemic https://bit.ly/2FRAGLO